Which of the following medicine should be administered in a client with atrial fibrillation on priority basis to reduce the risk of MI?

1. A

   Amiodarone

2. B

   Heparin

3. C

   Atropine

4. D

   Adrenaline

Appeared in: NORCET-7 Mains-2024

Explanation

Listen in Hindi

• Atrial fibrillation (AF) causes ineffective atrial contraction, leading to blood stasis, particularly in the left atrial appendage.
• This stasis promotes the formation of thrombi (blood clots).
• If a thrombus dislodges, it can travel to the coronary arteries, causing a myocardial infarction (MI), or to the brain, causing a stroke.
• Heparin is a rapid-acting anticoagulant that prevents the formation of new clots, directly reducing the risk of such thromboembolic events.
• Therefore, initiating anticoagulation is the priority intervention to prevent complications like MI in a patient with AF.

Why Other Options Were Wrong

• Option A: Amiodarone is an antiarrhythmic drug used for rhythm or rate control. It does not prevent clot formation. Administering it before anticoagulation can be dangerous as restoring normal rhythm might dislodge an existing clot.
• Option C: Atropine is an anticholinergic drug used to increase the heart rate in cases of symptomatic bradycardia (slow heart rate). Atrial fibrillation is typically associated with a rapid ventricular rate, making atropine contraindicated.
• Option D: Adrenaline (epinephrine) is a potent sympathomimetic used in cardiac arrest. It drastically increases heart rate, contractility, and myocardial oxygen demand, which would be extremely detrimental to a patient with atrial fibrillation.

Related Visual

• Visual 1: Diagram - A comparison of blood flow in a normal heart versus a heart in atrial fibrillation. The visual should highlight the pooling of blood (stasis) in the left atrial appendage in AF.
• Visual 2: Flowchart - A flowchart illustrating the pathophysiology: Atrial Fibrillation → Ineffective Atrial Contraction → Blood Stasis → Thrombus Formation → Embolism → Myocardial Infarction or Stroke.

Clinical Relevance

• Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacological management of atrial fibrillation and prevention of thromboembolic complications as background academic context rather than a clinical decision trigger.
• In clinical practice, the CHA₂DS₂-VASc score is used to assess stroke risk in patients with AF and guide the need for long-term anticoagulation.
• Nurses play a critical role in monitoring patients on heparin for therapeutic effectiveness (via aPTT) and for adverse effects, most notably bleeding.
• Patient safety is paramount. The rule is often 'rate control and anticoagulation before rhythm control' to prevent dislodging a clot upon cardioversion.

How to Approach the Question

• Step 1: Identify the core clinical problem: The patient has atrial fibrillation (AF).
• Step 2: Identify the specific goal of the intervention: To reduce the risk of Myocardial Infarction (MI).
• Step 3: Recall the pathophysiology linking AF to MI. AF causes blood stasis, which leads to clot formation. These clots can embolize to the coronary arteries, causing an MI.
• Step 4: Analyze the options based on their primary mechanism of action in this context. Ask, 'Which drug directly addresses the risk of clot formation?'
• Step 5: Heparin is an anticoagulant; it prevents clots. Amiodarone is an antiarrhythmic; it controls rhythm. Atropine is for bradycardia. Adrenaline is for cardiac arrest.
• Step 6: Conclude that Heparin is the only option that directly targets the underlying cause of embolic MI in AF, making it the priority.

Concept Tested & Keywords

• Concept Tested: Pharmacological management of atrial fibrillation and prevention of thromboembolic complications.
• Stem keywords: atrial fibrillation, myocardial infarction (MI), priority, medicine
• Lead-in keywords: Which
• Clinical cues: The patient has atrial fibrillation, which is a primary risk factor for thromboembolism.

Question ID

QP031yPMyCpl5E--IbBjf1

Copy ID